Reversing/blocking t cell suppression by extracellular vesicles as cancer therapy
Ended Project Grant Awarded Last action
- Award ID
- R43CA224602
- Recipient
-
Immune Modulatory Therapies LLC UEI J453G5R8UMJ5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $280,902
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Funding
-
- $280,910.36 Federal
- -$8.82 Non-federal
- Place of performance
- Eden, NY 14057, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$9 | $0 | |
| Amendment | -$9 | -$9 | |
| Original award | $280,928 | $0 |
Quick answers
Who received award R43CA224602?
R43CA224602 was awarded to Immune Modulatory Therapies LLC by National Cancer Institute (National Institutes of Health) on May 1, 2018.
How much is award R43CA224602 worth?
$280,902 has been obligated on R43CA224602: $280,910 in federal funding and -$9 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award